Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of
cefuroxime at cord clamp for prevention of postcesarean infectious morbidity has not been
assessed.
Women scheduled for cesarean delivery were randomized to receive a single dose of either 3g
of ampicillin-sulbactam or 1.5g of cefuroxime intravenously, after umbilical cord clamping.
An evaluation for development of postoperative infections and risk factor analysis was
performed.